71 related articles for article (PubMed ID: 10865440)
1. [Effect of suprainhibitory (supra-MIC) concentration of clindamycin on endotoxin release from Bacteroides fragilis].
Rokosz A; Meisel-Mikołajczyk F
Med Dosw Mikrobiol; 1999; 51(1-2):143-9. PubMed ID: 10865440
[TBL] [Abstract][Full Text] [Related]
2. [Use of the LAL test for quantitative determination of Bacteroids fragilis endotoxin].
Rokosz A; Marciniak-Rusek A; Aleksandrowicz J; Meisel-Mikołajczyk F
Med Dosw Mikrobiol; 1997; 49(3-4):161-8. PubMed ID: 9554148
[TBL] [Abstract][Full Text] [Related]
3. [Detection of endotoxins and enterotoxins of Bacteroides fragilis in culture media].
Rokosz A; Kruszewska D; Rouyan GS; Meisel-Mikołajczyk F
Med Dosw Mikrobiol; 1997; 49(1-2):61-7. PubMed ID: 9411074
[TBL] [Abstract][Full Text] [Related]
4. [Production of enterotoxins by Bacteroids fragilis strains--effect of clindamycin].
Rokosz A; Rouyan GS; Meisel-Mikołajczyk F
Med Dosw Mikrobiol; 1997; 49(3-4):153-9. PubMed ID: 9554147
[TBL] [Abstract][Full Text] [Related]
5. Influence of clindamycin, metronidazole and polymyxin B on the expression of cell adhesion molecules stimulated by endotoxin and enterotoxin of Bacteroides fragilis.
Meisel-Mikołajczyk F; Rokosz A; Kot K; Zawidzka E; Malchar C; Nowaczyk M; Górski A
Acta Microbiol Pol; 2003; 52(4):361-72. PubMed ID: 15095923
[TBL] [Abstract][Full Text] [Related]
6. [Effect of clindamycin on stimulation of cell adhesion molecules by endotoxins and enterotoxin of Bacteroides fragilis strains].
Meisel-Mikołajczyk F; Rokosz A; Kot K; Zawidzka E; Malchar C; Nowaczyk M; Górski A
Med Dosw Mikrobiol; 2001; 53(2):151-60. PubMed ID: 11757424
[TBL] [Abstract][Full Text] [Related]
7. Characterization of bactericidal activity of clindamycin against Bacteroides fragilis via kill curve methods.
Klepser ME; Banevicius MA; Quintiliani R; Nightingale CH
Antimicrob Agents Chemother; 1996 Aug; 40(8):1941-4. PubMed ID: 8843310
[TBL] [Abstract][Full Text] [Related]
8. Influence of five antianaerobic antibiotics on endotoxin liberation by gram-negative anaerobes.
Rotimi VO; Verghese TL; Al-Sweih N; Khodakhast FB; Ahmed K
J Chemother; 2000 Feb; 12(1):40-7. PubMed ID: 10768514
[TBL] [Abstract][Full Text] [Related]
9. Susceptibility of anaerobic bacteria to five antimicrobial agents and demonstration of resistance of Bacteroides fragilis to clindamycin.
Sofianou D; Douboyas J; Papapanagiotou J; Paradelis AG
Methods Find Exp Clin Pharmacol; 1982; 4(3):173-7. PubMed ID: 7121128
[TBL] [Abstract][Full Text] [Related]
10. Relative antibacterial efficacy of clindamycin and metronidazole against Bacteroides fragilis in vitro and in experimentally infected mice.
Dijkmans BA; Vaishnav J; Mattie H
Chemotherapy; 1985; 31(4):297-303. PubMed ID: 4028873
[TBL] [Abstract][Full Text] [Related]
11. Inducible metronidazole resistance in nim-positive and nim-negative bacteroides fragilis group strains after several passages metronidazole containing columbia agar plates.
Schaumann R; Petzold S; Fille M; Rodloff AC
Infection; 2005 Oct; 33(5-6):368-72. PubMed ID: 16258869
[TBL] [Abstract][Full Text] [Related]
12. [The effect of oxygen on endotoxin production in bacteria of the Bacteroides fragilis group isolated from patients with colorectal carcinoma].
Chmelař D; Hájek M; Janečková J; Vobejdová J; Martineková P; Kašíková A
Epidemiol Mikrobiol Imunol; 2016; 65(2):129-35. PubMed ID: 27467330
[TBL] [Abstract][Full Text] [Related]
13. Effect of subinhibitory doses of clindamycin on the virulence of Bacteroides fragilis: role of lipopolysaccharide.
Zaleznik DF; Zhang ZL; Onderdonk AB; Kasper DL
J Infect Dis; 1986 Jul; 154(1):40-6. PubMed ID: 3711690
[TBL] [Abstract][Full Text] [Related]
14. Increased resistance of encapsulated Bacteroides fragilis to clindamycin.
Brook I; Gillmore JD
Chemotherapy; 1994; 40(1):16-20. PubMed ID: 8306810
[TBL] [Abstract][Full Text] [Related]
15. Antibiotic sensitivity of the Bacteroides fragilis group in Denmark. Danish Study Group.
Bremmelgaard A; Jansen JE; Justesen T; Gottschau A
APMIS; 1993 Sep; 101(9):727-31. PubMed ID: 8240792
[TBL] [Abstract][Full Text] [Related]
16. Low endotoxin release from Escherichia coli and Bacteroides fragilis during exposure to moxifloxacin.
Trautmann M; Scheibe C; Wellinghausen N; Holst O; Lepper PM
Chemotherapy; 2010; 56(5):364-70. PubMed ID: 20926860
[TBL] [Abstract][Full Text] [Related]
17. Pharmacodynamics of pulse dosing versus standard dosing: in vitro metronidazole activity against Bacteroides fragilis and Bacteroides thetaiotaomicron.
Ibrahim KH; Gunderson BW; Hermsen ED; Hovde LB; Rotschafer JC
Antimicrob Agents Chemother; 2004 Nov; 48(11):4195-9. PubMed ID: 15504841
[TBL] [Abstract][Full Text] [Related]
18. [Selected properties of Bacteroides fragilis enterotoxigenic strains].
Rokosz A; Meisel-Mikołajczyk F
Med Dosw Mikrobiol; 1995; 47(3-4):183-8. PubMed ID: 8833930
[TBL] [Abstract][Full Text] [Related]
19. Bacteroides fragilis group: trends in resistance.
Fille M; Mango M; Lechner M; Schaumann R
Curr Microbiol; 2006 Feb; 52(2):153-7. PubMed ID: 16450067
[TBL] [Abstract][Full Text] [Related]
20. Development of EUCAST disk diffusion method for susceptibility testing of the Bacteroides fragilis group isolates.
Nagy E; Justesen US; Eitel Z; Urbán E;
Anaerobe; 2015 Feb; 31():65-71. PubMed ID: 25464140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
